免疫組織化学（IHC）の世界市場レポート 2025年

免疫組織化学（IHC）市場規模は、今後数年で急成長が見込まれます。2029年には41億3,000万米ドルに成長し、CAGRは10.4％に達します。予測期間の成長は、新規プレイヤーの市場参入、医薬品開発、生物医学研究統合、診断アプリケーション、自動化、デジタル化の需要に起因します。予測期間における主な動向としては、マルチプレックスIHC技術、デジタル病理統合、抗体特異性の向上、自動化と標準化、バイオマーカー探索への応用などが挙げられます。

免疫組織化学（IHC）市場は、慢性疾患の有病率の増加により成長が見込まれています。慢性疾患とは、長期にわたり持続し、一般的に管理は可能であるが治癒は不可能なものであり、がんや心血管障害などの疾患が含まれます。免疫組織化学は、特異性、特定の抗原を検出する感度、迅速な結果といった利点を提供し、これらの疾患の診断に極めて重要です。2022年、米国疾病予防管理センター（Centers for Disease Control and Prevention）は、米国では人口の11.3%を占める約3,730万人が糖尿病に罹患していると報告し、慢性疾患の負担増に対処する上で免疫組織化学が果たす役割を強調しています。

免疫組織化学（IHC）市場の成長は、個別化医療に対する需要の増加によってさらに促進されます。個別化医療は、個々の患者固有の遺伝的、環境的、ライフスタイル的特徴に基づいて、医療上の決定や介入を調整するものです。免疫組織化学はこの文脈で重要な役割を果たし、腫瘍の正確な分類と診断に不可欠な特異的タンパク質マーカーを検出します。個別化医療連合（Personalized Medicine Coalition）は、75,000以上の遺伝子検査製品と300以上の個別化医薬品が様々な疾患に対して利用可能になると予測しており、個別化医療の進歩における免疫組織化学の極めて重要な役割を強調しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界免疫組織化学（IHC） PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、制約）
• 最終用途産業の分析
• 世界の免疫組織化学（IHC）市場：成長率分析
• 世界の免疫組織化学（IHC）市場の実績：規模と成長, 2019-2024
• 世界の免疫組織化学（IHC）市場の予測：規模と成長, 2024-2029, 2034F
• 世界免疫組織化学（IHC）総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の免疫組織化学（IHC）市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗体
• 装置
• 試薬
• キット
• 世界の免疫組織化学（IHC）市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断
• 薬物検査
• その他の用途
• 世界の免疫組織化学（IHC）市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院および診断研究所
• 調査機関
• その他のエンドユーザー
• 世界の免疫組織化学（IHC）市場抗体のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 一次抗体
• 二次抗体
• 結合抗体
• 世界の免疫組織化学（IHC）市場、機器のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• IHC染色システム
• 組織処理装置
• スライドスキャナ
• 顕微鏡
• 世界の免疫組織化学（IHC）市場、試薬の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 検出試薬
• ブロッキング試薬
• マウントメディア
• 顕微鏡
• 世界の免疫組織化学（IHC）市場、キットのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 調製済みIHCキット
• マルチプレックスIHCキット
• 特殊キット

第7章 地域別・国別分析

• 世界の免疫組織化学（IHC）市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の免疫組織化学（IHC）市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 免疫組織化学（IHC）市場：競合情勢
• 免疫組織化学（IHC）市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • The Merck Group Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bio-Rad Laboratories Inc.
• Cell Signaling Technology Inc.
• Bio SB Inc.
• Agilent Technologies Inc.
• Abcam plc
• Becton Dickinson and Company
• Takara Bio Inc.
• Biocare Medical LLC
• Bio-Genex Laboratories
• Diagnostic BioSystems Inc.
• BioVision Inc.
• PHC Holdings Corporation
• Abbott Laboratories
• Leica Biosystems
• Vector Laboratories

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 免疫組織化学（IHC）市場2029：新たな機会を提供する国
• 免疫組織化学（IHC）市場2029：新たな機会を提供するセグメント
• 免疫組織化学（IHC）市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Immunohistochemistry (IHC) is a diagnostic technique that utilizes the interaction between antibodies and antigens to identify specific proteins and antigens within tissue sections. This interaction is visualized through chromogenic detection using enzyme-substrate or fluorescent detection using fluorescent dyes.

The main products associated with immunohistochemistry (IHC) include antibodies, equipment, reagents, and kits. Antibodies are proteins produced by the immune system to neutralize harmful antigens, and in the context of IHC, they are employed to detect the specific location of proteins or antigens for diagnostic purposes. The applications of IHC span diagnostics, drug testing, and other related areas, with end-users including hospitals, diagnostic laboratories, research institutes, and others.

The immunohistochemistry (IHC) market research report is one of a series of new reports from The Business Research Company that provides immunohistochemistry (IHC) market statistics, including immunohistochemistry (IHC) industry global market size, regional shares, competitors with a immunohistochemistry (IHC) market share, detailed immunohistochemistry (IHC) market segments, market trends and opportunities, and any further data you may need to thrive in the immunohistochemistry (IHC) industry. This immunohistochemistry (IHC) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immunohistochemistry (IHC) market size has grown strongly in recent years. It will grow from $2.58 billion in 2024 to $2.78 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to clinical adoption, industry standardization, expansion in cancer research, automation in laboratories, clinical diagnostics advancements.

The immunohistochemistry (IHC) market size is expected to see rapid growth in the next few years. It will grow to $4.13 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to market entry of new players, demand in drug development, biomedical research integration, diagnostic applications, automation and digitalization. Major trends in the forecast period include multiplex IHC techniques, digital pathology integration, enhanced antibody specificity, automation and standardization, application in biomarker discovery.

The immunohistochemistry (IHC) market is anticipated to witness growth due to the increasing prevalence of chronic diseases. Chronic diseases, lasting for extended periods and typically manageable but not curable, include conditions such as cancer and cardiovascular disorders. Immunohistochemistry is crucial in diagnosing these diseases, offering advantages such as specificity, sensitivity to detect specific antigens, and rapid results. In 2022, the Centers for Disease Control and Prevention reported that approximately 37.3 million people in the United States, accounting for 11.3% of the population, have diabetes, emphasizing the role of immunohistochemistry in addressing the rising burden of chronic diseases.

The growth of the immunohistochemistry (IHC) market is further driven by the increasing demand for personalized medicines. Personalized medicine tailors medical decisions and interventions based on individual patients' unique genetic, environmental, and lifestyle characteristics. Immunohistochemistry plays a significant role in this context, detecting specific protein markers crucial for accurate tumor classification and diagnosis. The Personalized Medicine Coalition projected that over 75,000 genetic testing products and 300 personalized medicines will be available for various diseases, reinforcing the pivotal role of immunohistochemistry in advancing personalized medicine.

Major players in the immunohistochemistry (IHC) market are concentrating on improving diagnostic accuracy through innovative technologies and high-quality reagents to enhance tissue analysis effectiveness in various clinical and research contexts. The Neoflex multiomics mass spectrometry imaging (MSI) system is a cutting-edge imaging platform tailored for precise tissue analysis, enabling researchers to progress from discovery to clinical applications using high-resolution mass spectrometry techniques, especially for spatially mapping biomolecules in tissues. For example, in June 2024, Bruker Corporation, a US-based company that develops and manufactures scientific instruments along with analytical and diagnostic solutions, introduced its matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF/TOF) Neoflex Imaging Profiler for mass spectrometry-based tissue imaging. The Neoflex MSI system addresses the demand for advancing from discovery imaging to clinical tissue research. It incorporates Bruker's 10-kHz smartbeam 3D laser, improved imaging detectors, and supports OME-TIFF file output with SCiLS Scope software.

Leading companies in the immunohistochemistry (IHC) market are prioritizing technological advancements, such as automated staining systems, to boost diagnostic accuracy and efficiency for pathologists, ultimately improving patient outcomes. The Tissue-Tek Genie represents an innovative, fully automated staining system for immunohistochemistry (IHC) and in situ hybridization (ISH), designed to deliver rapid, high-quality, and standardized results to enhance diagnostic precision in histopathology. For instance, in September 2022, Sakura Finetek, a US-based medical equipment company, launched its latest solution, Tissue-Tek Genie, an advanced staining system focused on providing optimal scoring antibodies for the best possible results for pathologists and their patients. The Tissue-Tek Genie Advanced Staining System is the first fully automated, true random access stainer for immunohistochemistry (IHC) and in situ hybridization (ISH).

In November 2022, Leica Biosystems, a Germany-based medical devices firm, acquired Cell IDx, Inc. for an undisclosed sum. This acquisition aims to enhance Leica Biosystems' multiplex immunohistochemistry (IHC) capabilities and improve cancer diagnostics by integrating its UltraPlex technology for advanced biomarker detection and tissue-based diagnostics. Cell IDx is a US-based biotechnology company specializing in multiplexed tissue profiling.

Major companies operating in the immunohistochemistry (IHC) market include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, The Merck Group, Danaher Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB Inc., Agilent Technologies Inc., Abcam plc, Becton Dickinson and Company, Takara Bio Inc., Biocare Medical LLC, Bio-Genex Laboratories, Diagnostic BioSystems Inc., BioVision Inc., PHC Holdings Corporation, Abbott Laboratories, Leica Biosystems, Vector Laboratories, Indivumed GmbH, Qritive, Ionpath Inc., Reveal Biosciences, Akrivis Technologies Private Limited, LifeSpan BioSciences Inc., Enzo Life Sciences Inc., Epitomics Inc., GenScript Biotech, Histologix Ltd., NeoGenomics Laboratories Inc.

North America was the largest region in the immunohistochemistry (IHC) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the immunohistochemistry (IHC) market report during the forecast period. The regions covered in the immunohistochemistry (ihc) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the immunohistochemistry (ihc) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The immunohistochemistry (IHC) market consists of sales of primary antibodies, slide staining system, tissue microarrays, tissue processing systems, slide scanners secondary antibodies, histological stains, blocking sera and reagents, chromogenic substrates, fixation reagents and stabilizers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunohistochemistry (IHC) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on immunohistochemistry (ihc) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunohistochemistry (ihc) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The immunohistochemistry (ihc) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Antibodies; Equipment; Reagents; Kits
• 2) By Applications: Diagnostics; Drug Testing; Other Applications
• 3) By End-Users: Hospitals And Diagnostic Laboratories; Research Institutes; Other End-Users
• Subsegments:
• 1) By Antibodies: Primary Antibodies; Secondary Antibodies; Conjugated Antibodies
• 2) By Equipment: IHC Staining Systems; Tissue Processors; Slide Scanners; Microscopes
• 3) By Reagents: Detection Reagents; Blocking Reagents; Mounting Media
• 4) By Kits: Pre-prepared IHC Kits; Multiplex IHC Kits; Specialty Kits
• Companies Mentioned: Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche AG; The Merck Group; Danaher Corporation; PerkinElmer Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Immunohistochemistry (IHC) Market Characteristics

3. Immunohistochemistry (IHC) Market Trends And Strategies

4. Immunohistochemistry (IHC) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Immunohistochemistry (IHC) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Immunohistochemistry (IHC) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Immunohistochemistry (IHC) Market Growth Rate Analysis
• 5.4. Global Immunohistochemistry (IHC) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Immunohistochemistry (IHC) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Immunohistochemistry (IHC) Total Addressable Market (TAM)

6. Immunohistochemistry (IHC) Market Segmentation

• 6.1. Global Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibodies
• Equipment
• Reagents
• Kits
• 6.2. Global Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostics
• Drug Testing
• Other Applications
• 6.3. Global Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Diagnostic Laboratories
• Research Institutes
• Other End-Users
• 6.4. Global Immunohistochemistry (IHC) Market, Sub-Segmentation Of Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Primary Antibodies
• Secondary Antibodies
• Conjugated Antibodies
• 6.5. Global Immunohistochemistry (IHC) Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• IHC Staining Systems
• Tissue Processors
• Slide Scanners
• Microscopes
• 6.6. Global Immunohistochemistry (IHC) Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Detection Reagents
• Blocking Reagents
• Mounting Media
• Microscopes
• 6.7. Global Immunohistochemistry (IHC) Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pre-prepared IHC Kits
• Multiplex IHC Kits
• Specialty Kits

7. Immunohistochemistry (IHC) Market Regional And Country Analysis

• 7.1. Global Immunohistochemistry (IHC) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Immunohistochemistry (IHC) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Immunohistochemistry (IHC) Market

• 8.1. Asia-Pacific Immunohistochemistry (IHC) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Immunohistochemistry (IHC) Market

• 9.1. China Immunohistochemistry (IHC) Market Overview
• 9.2. China Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Immunohistochemistry (IHC) Market

• 10.1. India Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Immunohistochemistry (IHC) Market

• 11.1. Japan Immunohistochemistry (IHC) Market Overview
• 11.2. Japan Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Immunohistochemistry (IHC) Market

• 12.1. Australia Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Immunohistochemistry (IHC) Market

• 13.1. Indonesia Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Immunohistochemistry (IHC) Market

• 14.1. South Korea Immunohistochemistry (IHC) Market Overview
• 14.2. South Korea Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Immunohistochemistry (IHC) Market

• 15.1. Western Europe Immunohistochemistry (IHC) Market Overview
• 15.2. Western Europe Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Immunohistochemistry (IHC) Market

• 16.1. UK Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Immunohistochemistry (IHC) Market

• 17.1. Germany Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Immunohistochemistry (IHC) Market

• 18.1. France Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Immunohistochemistry (IHC) Market

• 19.1. Italy Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Immunohistochemistry (IHC) Market

• 20.1. Spain Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Immunohistochemistry (IHC) Market

• 21.1. Eastern Europe Immunohistochemistry (IHC) Market Overview
• 21.2. Eastern Europe Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Immunohistochemistry (IHC) Market

• 22.1. Russia Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Immunohistochemistry (IHC) Market

• 23.1. North America Immunohistochemistry (IHC) Market Overview
• 23.2. North America Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Immunohistochemistry (IHC) Market

• 24.1. USA Immunohistochemistry (IHC) Market Overview
• 24.2. USA Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Immunohistochemistry (IHC) Market

• 25.1. Canada Immunohistochemistry (IHC) Market Overview
• 25.2. Canada Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Immunohistochemistry (IHC) Market

• 26.1. South America Immunohistochemistry (IHC) Market Overview
• 26.2. South America Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Immunohistochemistry (IHC) Market

• 27.1. Brazil Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Immunohistochemistry (IHC) Market

• 28.1. Middle East Immunohistochemistry (IHC) Market Overview
• 28.2. Middle East Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Immunohistochemistry (IHC) Market

• 29.1. Africa Immunohistochemistry (IHC) Market Overview
• 29.2. Africa Immunohistochemistry (IHC) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Immunohistochemistry (IHC) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Immunohistochemistry (IHC) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Immunohistochemistry (IHC) Market Competitive Landscape And Company Profiles

• 30.1. Immunohistochemistry (IHC) Market Competitive Landscape
• 30.2. Immunohistochemistry (IHC) Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. The Merck Group Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Immunohistochemistry (IHC) Market Other Major And Innovative Companies

• 31.1. Bio-Rad Laboratories Inc.
• 31.2. Cell Signaling Technology Inc.
• 31.3. Bio SB Inc.
• 31.4. Agilent Technologies Inc.
• 31.5. Abcam plc
• 31.6. Becton Dickinson and Company
• 31.7. Takara Bio Inc.
• 31.8. Biocare Medical LLC
• 31.9. Bio-Genex Laboratories
• 31.10. Diagnostic BioSystems Inc.
• 31.11. BioVision Inc.
• 31.12. PHC Holdings Corporation
• 31.13. Abbott Laboratories
• 31.14. Leica Biosystems
• 31.15. Vector Laboratories

32. Global Immunohistochemistry (IHC) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Immunohistochemistry (IHC) Market

34. Recent Developments In The Immunohistochemistry (IHC) Market

35. Immunohistochemistry (IHC) Market High Potential Countries, Segments and Strategies

• 35.1 Immunohistochemistry (IHC) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Immunohistochemistry (IHC) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Immunohistochemistry (IHC) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer